Decloedt EH - Search Results

1

Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis.

Abulfathi AA, Decloedt EH, Svensson EM, Diacon AH, Donald P, Reuter H. Abulfathi AA, et al. Among authors: decloedt eh. Clin Pharmacokinet. 2019 Sep;58(9):1103-1129. doi: 10.1007/s40262-019-00764-2. Clin Pharmacokinet. 2019. PMID: 31049868 Review.

2

Effectiveness and safety of antiretrovirals with rifampicin: crucial issues for high-burden countries.

Maartens G, Decloedt E, Cohen K. Maartens G, et al. Antivir Ther. 2009;14(8):1039-43. doi: 10.3851/IMP1455. Antivir Ther. 2009. PMID: 20032533 Review.

3

Model-based approach to dose optimization of lopinavir/ritonavir when co-administered with rifampicin.

Zhang C, Denti P, Decloedt E, Maartens G, Karlsson MO, Simonsson US, McIlleron H. Zhang C, et al. Br J Clin Pharmacol. 2012 May;73(5):758-67. doi: 10.1111/j.1365-2125.2011.04154.x. Br J Clin Pharmacol. 2012. PMID: 22126409 Free PMC article.

4

The safety, effectiveness and concentrations of adjusted lopinavir/ritonavir in HIV-infected adults on rifampicin-based antitubercular therapy.

Decloedt EH, Maartens G, Smith P, Merry C, Bango F, McIlleron H. Decloedt EH, et al. PLoS One. 2012;7(3):e32173. doi: 10.1371/journal.pone.0032173. Epub 2012 Mar 7. PLoS One. 2012. PMID: 22412856 Free PMC article.

5

Model-based evaluation of the pharmacokinetic differences between adults and children for lopinavir and ritonavir in combination with rifampicin.

Zhang C, Denti P, Decloedt EH, Ren Y, Karlsson MO, McIlleron H. Zhang C, et al. Among authors: decloedt eh. Br J Clin Pharmacol. 2013 Nov;76(5):741-51. doi: 10.1111/bcp.12101. Br J Clin Pharmacol. 2013. PMID: 23432610 Free PMC article. Clinical Trial.

6

Central nervous system penetration of antiretroviral drugs: pharmacokinetic, pharmacodynamic and pharmacogenomic considerations.

Decloedt EH, Rosenkranz B, Maartens G, Joska J. Decloedt EH, et al. Clin Pharmacokinet. 2015 Jun;54(6):581-98. doi: 10.1007/s40262-015-0257-3. Clin Pharmacokinet. 2015. PMID: 25777740

7

Angio-oedema associated with colistin.

Abulfathi AA, Greyling T, Makiwane M, Esser M, Decloedt E. Abulfathi AA, et al. S Afr Med J. 2016 Sep 4;106(10):990-991. doi: 10.7196/SAMJ.2016.v106i10.10835. S Afr Med J. 2016. PMID: 27725018

8

Evaluation of the Effectiveness of Dose Individualization to Achieve Therapeutic Vancomycin Concentrations.

Abulfathi AA, Chirehwa M, Rosenkranz B, Decloedt EH. Abulfathi AA, et al. Among authors: decloedt eh. J Clin Pharmacol. 2018 Sep;58(9):1134-1139. doi: 10.1002/jcph.1254. Epub 2018 May 10. J Clin Pharmacol. 2018. PMID: 29746714

9

Benefit v. risk when using chloroquine in patients with severe COVID-19 disease.

Decloedt EH, Reuter H, Allwood B, Parker A, Koegelenberg CFN, Blockman M, Taljaard J. Decloedt EH, et al. S Afr Med J. 2020 Apr 2;110(5):12903. doi: 10.7196/SAMJ.2020.v110i5.14761. S Afr Med J. 2020. PMID: 32657706 No abstract available.

10

Incident tuberculosis disease in patients receiving biologic therapies in the Western Cape, South Africa from 2007 to 2018.

du Toit T, Esterhuizen TM, Tiffin N, Abulfathi AA, Reuter H, Decloedt EH. du Toit T, et al. Among authors: decloedt eh. BMC Infect Dis. 2020 Nov 30;20(1):900. doi: 10.1186/s12879-020-05624-0. BMC Infect Dis. 2020. PMID: 33256634 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters